Plain-English translation of NCT05889585 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is following men who were treated for germ-cell tumor (a type of cancer) and have remained cancer-free for at least 3 years. Researchers want to understand the long-term physical and emotional side effects that survivors experience after intensive chemotherapy and stem cell transplant treatment. Because most people diagnosed with germ-cell tumor are under 40, they may live 30–50 more years, so understanding these long-term effects is important for their quality of life.
Young germ-cell tumor survivors who receive intensive chemotherapy can live for decades after treatment, but little is known about how this medication affects their health, relationships, work, and overall well-being in the long run. This study aims to gather that information so doctors can better support survivors and help them manage side effects.
You likely qualify if…
You likely don't qualify if…
You would meet with researchers who will ask you detailed questions about your cancer treatment, your current health, any side effects you have experienced, and how the cancer and treatment have affected your work, relationships, and daily life. The study compares three groups: men who received high-dose chemotherapy with stem cell transplant, men who had surgery only, and men who received standard chemotherapy. Your participation helps doctors understand what long-term challenges survivors face so they can provide better care and support.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
France